Infection control policies and procedures for meticillin-resistant Staphylococcus aureus in care homes for older people in Northern Ireland: a questionnaire study

Autor: MM Tunney, J. Magee, CM Hughes

Publikováno v: British Journal of Infection Control. 7:20-24

ackground: Limited information is available regarding the role of infection control in the prevention of infection in nursing and residential care homes. Objectives: To determine what infection control policies and procedures are in place in care hom

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::539cbc9b2665647a352904a397c4f6ef
https://doi.org/10.1177/14690446060070060601

Views of undergraduate pharmacy students and pre-registration pharmacy graduates on continuing professional development (CPD)

Autor: SL Haughey, HE Barry, CM Hughes, CG Adair, HM Bell

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4cdeace3746b3069104b28a0c90dbe9f

Potentially inappropriate prescribing in two populations with differing socio-economic profiles: a cross-sectional database study using the PROMPT criteria

Autor: Ja, Cooper, Frank Moriarty, Ryan C, Sm, Smith, Bennett K, Fahey T, Wallace E, Cahir C, Williams D, Teeling M, Cm, Hughes

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3d2f2646b9dedbcc56bea23d5d1c9a85
http://europepmc.org/abstract/med/26820292

Selection of outcome measurement instruments for a core outcome set for trials aimed at improving appropriate polypharmacy in older people in primary care: a Delphi consensus study.

Autor: Alqahtani MN; Primary Care Research Group, School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK., Barry HE; Primary Care Research Group, School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK., Hughes CM; Primary Care Research Group, School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK. c.hughes@qub.ac.uk.

Publikováno v: International journal of clinical pharmacy [Int J Clin Pharm] 2024 Dec; Vol. 46 (6), pp. 1391-1399. Date of Electronic Publication: 2024 Jul 23.

Human cytomegalovirus UL18 prevents priming of MHC-E- and MHC-II-restricted CD8 ⁺ T cells.

Autor: Malouli D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Taher H; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Mansouri M; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Iyer RF; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Reed J; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Papen C; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Schell JB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Beechwood T; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Martinson T; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Morrow D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Hughes CM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Gilbride RM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Randall K; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Ford JC; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Belica K; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Ojha S; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Sacha JB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Bimber BN; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Hansen SG; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Picker LJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Früh K; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.

Publikováno v: Science immunology [Sci Immunol] 2024 Oct 11; Vol. 9 (100), pp. eadp5216. Date of Electronic Publication: 2024 Oct 11.